or
forgot password

Pivotal Validation Study of Salivary Biomarkers for the Risk Stratification of Patients With Lesions Suspicious for Oral Squamous Cell Carcinoma


N/A
18 Years
N/A
Open (Enrolling)
Both
Oral Squamous Cell Cancer

Thank you

Trial Information

Pivotal Validation Study of Salivary Biomarkers for the Risk Stratification of Patients With Lesions Suspicious for Oral Squamous Cell Carcinoma


Inclusion Criteria:



- Adult patients scheduled for biopsy of an oral lesion suspicious for squamous cell
cancer

Exclusion Criteria:

- Patients with known prior malignancy or with immune deficiency

Type of Study:

Observational

Study Design:

Observational Model: Case Control, Time Perspective: Prospective

Outcome Measure:

Test specificity over 50% at 90% sensitivity

Outcome Time Frame:

at study completion

Safety Issue:

No

Principal Investigator

Barry Wenig, MD

Investigator Role:

Principal Investigator

Investigator Affiliation:

Michigan State University

Authority:

United States: Institutional Review Board

Study ID:

PeriRx-1

NCT ID:

NCT01587573

Start Date:

April 2012

Completion Date:

May 2014

Related Keywords:

  • Oral Squamous Cell Cancer
  • salivary biomarkers
  • Carcinoma, Squamous Cell
  • Neoplasms, Squamous Cell

Name

Location
University of Michigan Ann Arbor, Michigan  48109-0624
Department of Surgery, Michigan Sate University East Lansing, Michigan  48912